Customized research for SYBX vs. AMGN!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for SYBX vs. AMGN.


↗ Join Our Free Email Newsletter.




Synlogic Inc. vs. Amgen, Inc.

Industry Match! Industry of Both SYBX and AMGN:

Health Care/Life Sciences

SYBX
Data Last Updated: 2 days ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 80.601M


P/E: N/A

P/S: 31.98

Q P/B: 0.45

Y Rev: 2.52M

Q Rev: 350,000

Beta: 2.72

SYBX Share Stats

Outstanding Shares

31.73M

Float Shares

16.49M

Percent of Float Short

7.76%

SYBX Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

SYBX Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

SYBX in Pulse Portal

Stream of Posts

SYBX Symbol Page

Share SYBX Insights

Express Sentiment

'Buy' or 'Sell' SYBX

SYBX Profile

CEO

Dr. Aoife M. Brennan

Exchange

Nasdaq

Employees

74.00

About

Synlogic, Inc. is a clinical-stage biopharmaceutical company, which engages in drug discovery and development of synthetic biotic medicines. It focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also works...

SYBX Financials

Annual Financials

Income Statement

Revenue

2.52M

Net Income

(48.44M)

Cash Flow Statement

Change in Cash / Investments

(47.19M)

Balance Sheet

Cash / Investments

122.73M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

124.34M

Total Current Liabilities

8.34M

Total Assets

140.34M

Total Liabilities

16.24M

Stockholder Equity

124.1M

Quarterly Financials

Income Statement

Q Revenue

350,000

Q Net Income

(12.34M)

Cash Flow Statement

Q Change in Cash / Investments

1.7M

Balance Sheet

Q Cash / Investments

129.01M

Q Short Term Debt

2.13M

Q Long Term Debt

None

Q Total Current Assets

162.9M

Q Total Current Liabilities

11.29M

Q Total Assets

214.95M

Q Total Liabilities

34.12M

Q Stockholder Equity

180.82M

SYBX Charts

10-Year Chart

SYBX 10-Year Chart

5-Year Chart

SYBX 5-Year Chart

1-Year Chart

SYBX 1-Year Chart

6-Month Chart

SYBX 6-Month Chart

3-Month Chart

SYBX 3-Month Chart

1-Month Chart

SYBX 1-Month Chart

1-Day Chart

SYBX 1-Day Chart

AMGN
Data Last Updated: 2 days ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 117.224B


P/E: 15.52

P/S: 4.93

Q P/B: 10.86

Y Rev: 23.77B

Q Rev: 5.85B

Beta: 0.80

AMGN Share Stats

Outstanding Shares

609.94M

Float Shares

598.44M

Percent of Float Short

1.42%

AMGN Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

AMGN Social Stats

Followers

1

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

AMGN in Pulse Portal

Stream of Posts

AMGN Symbol Page

Share AMGN Insights

Express Sentiment

'Buy' or 'Sell' AMGN

AMGN Profile

CEO

Mr. Robert A. Bradway

Exchange

Nasdaq

Employees

21,500

About

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate,...

AMGN Financials

Annual Financials

Income Statement

Revenue

23.77B

Net Income

8.39B

Cash Flow Statement

Change in Cash / Investments

3.15B

Balance Sheet

Cash / Investments

29.3B

Short Term Debt

None

Long Term Debt

29.51B

Total Current Assets

37.62B

Total Current Liabilities

13.49B

Total Assets

66.42B

Total Liabilities

53.92B

Stockholder Equity

12.5B

Quarterly Financials

Income Statement

Q Revenue

5.85B

Q Net Income

2.18B

Cash Flow Statement

Q Change in Cash / Investments

(1.83B)

Balance Sheet

Q Cash / Investments

21.76B

Q Short Term Debt

134M

Q Long Term Debt

27.8B

Q Total Current Assets

30.75B

Q Total Current Liabilities

10.62B

Q Total Assets

59.37B

Q Total Liabilities

48.58B

Q Stockholder Equity

10.79B

AMGN Charts

10-Year Chart

AMGN 10-Year Chart

5-Year Chart

AMGN 5-Year Chart

1-Year Chart

AMGN 1-Year Chart

6-Month Chart

AMGN 6-Month Chart

3-Month Chart

AMGN 3-Month Chart

1-Month Chart

AMGN 1-Month Chart

1-Day Chart

AMGN 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon